Silver Spike Acquisition Corp II
SPKBW
NASDAQ Capital Market0.00
USD
- -
- -
CIK
0001826435
CUSIP
G8201H113
Return %
Stock
S&P500
1Y
-98.96
26.84
3Y
-99.75
77.03
5Y
-99.75
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Scott Gordon
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 660 Madison Avenue New York City NY United States of America
- IPO Date
- May 3, 2021
- CIK
- 0001826435
- Similar Companies
- Business
- Silver Spike Acquisition Corp II (SPKBW) operates as a blank check company whose principal activity is to effect a merger, amalgamation, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, with a focus on the cannabis industry and compliant operations in health, wellness, and related sectors. The company offers no substantive products or services beyond its SPAC structure, including Class A ordinary shares, redeemable units, and warrants traded under tickers SPKB, SPKBU, and SPKBW; it maintains a trust account for potential target acquisitions funded initially through its $250 million IPO priced at $10.00 per unit in March 2021. Headquartered in New York, New York, and founded in 2020 as a Cayman Islands exempted company, it targets businesses in the United States and potentially other jurisdictions adhering to applicable laws. In March 2023, Silver Spike Acquisition Corp II announced the redemption of all outstanding Class A ordinary shares at approximately $10.22 per share, effective March 27, 2023, after failing to complete an initial business combination within the required 24-month period following its IPO, leading to cessation of operations except for winding up, cancellation of shares, and delisting from Nasdaq. The company had previously entered a business combination agreement with Eleusis Holdings Limited in January 2022 to take the psychedelics developer public, which was mutually terminated in June 2022 due to unfavorable market conditions. As of late 2025, its warrants (SPKBW) trade minimally with potential delisting status, and no further mergers, acquisitions, funding, or operational restarts have occurred, positioning it in the defunct SPAC segment post-liquidation.